LAKEWOOD, Ohio -- Lakewood residents can claim a free native tree this fall through the city’s Tree Giveaway Program, which aims to expand the community’s tree canopy with 200 trees available for home ...
Perplexity is offering students one free month of Perplexity Pro. The company is positioning Comet as "study buddy, and tutor." AI is rapidly becoming a fixture in the classroom. Like it or not, ...
Brinsupri FDA approval, with strong sales potential and M&A interest. Click here to find out why INSM stock is a Buy.
New users can earn $200 in bonus bets and over $200 off NFL Sunday Ticket with the latest DraftKings promo code, and there are plenty of intriguing NFL betting picks on Sunday. The Eagles are favored ...
The wait is over! Bills Mafia finally gets to gear up for another season of Buffalo football. Week 1 sets the stage with a primetime battle against the Baltimore Ravens on Sunday Night Football, and ...
The NFL season resumes on Thursday with the Green Bay Packers hosting the Washington Commanders on Thursday Night Football at Lambeau Field. With the upgraded DraftKings promo code, new users receive ...
Apple doesn’t usually play in the budget box, but here we are. The iPhone 13 is sleek, powerful, and still one of the smoothest phones to use daily. At 20% off, it’s real value in every sense. The ...
Inertia-based, flywheel-battery hybrid system delivers faster, more durable energy storage Investment comes at inflection point in growth of energy demand driven by artificial intelligence and cloud ...
Trump condemns ‘brutal’ beheading of motel manager killed in front of his family and vows justice When Trump met the Queen and it all went wrong Top Starmer aide quits Government after ‘appalling’ ...
TechCrunch’s Startup Battlefield 200 is where the world’s most innovative early-stage startups take center stage in a pitch competition like no other. With over 1,500 alumni like Trello, Mint, Dropbox ...
A new targeted therapy has shown promise for a difficult-to-treat subset of lung cancer. In a multinational phase 2 trial, the oral drug sunvozertinib produced durable tumor responses in patients with ...